The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures
- PMID: 3497887
- DOI: 10.1016/0192-0561(87)90021-x
The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures
Abstract
The immunosuppressive potency of five natural and seven synthetic steroids were tested in vitro on phytohemagglutinin (PHA) stimulated peripheral lymphocytes (PBL) and T-lymphocytes and compared to their anti-inflammatory potencies. The physiological glucocorticoid, hydrocortisone, was of intermediate immunosuppressive potency in vitro, whereas the metabolites of hydrocortisone (cortisone, dihydrocortisol, and tetrahydrocortisol) and aldosterone were without effect. The synthetic steroids, methylprednisolone and fluorohydrocortisone were both highly potent in suppressing the PHA responses of both lymphocyte subsets. Prednisolone and dexamethasone were of intermediate potency and ranked similar to hydrocortisone which is in contrast to their anti-inflammatory properties. Prednisone, the biologically inactive metabolite of prednisolone, was without immunosuppressive properties. Deoxy-deflazacort, the biologically active metabolite of deflazacort (a new oxazoline derivative of prednisolone) was comparable to prednisolone and hydrocortisone in suppressing lymphocyte proliferation but again there was a large discrepancy between the in vitro immunosuppressive effect and the anti-inflammatory potency. In conclusion, the present assay may therefore separate the immunosuppressive properties from the anti-inflammatory properties of glucocorticoids. These findings may be useful for comparison of new synthetic steroids.
Similar articles
-
The immunosuppressive potency of various steroids on peripheral blood lymphocytes, T cells, NK and K cells.Int J Immunopharmacol. 1985;7(4):483-9. doi: 10.1016/0192-0561(85)90067-0. Int J Immunopharmacol. 1985. PMID: 3876294
-
In vitro immunosuppressive potency of deflazacort, a new bone-sparing corticosteroid on T lymphocytes, NK and K cells.Br J Clin Pharmacol. 1986 Feb;21(2):125-9. doi: 10.1111/j.1365-2125.1986.tb05165.x. Br J Clin Pharmacol. 1986. PMID: 3485440 Free PMC article.
-
Relative immunosuppressive potency of various corticosteroids measured in vitro.Eur J Clin Pharmacol. 1983;25(4):459-62. doi: 10.1007/BF00542111. Eur J Clin Pharmacol. 1983. PMID: 6653640
-
[Modification of in vitro immune mechanisms by various glucocorticosteroid preparations--studies of lymphocytes in healthy probands and autoimmune patients].Z Gesamte Inn Med. 1987 Mar 15;42(6):160-3. Z Gesamte Inn Med. 1987. PMID: 3496720 German.
-
Immunosuppressive and anti-inflammatory effects of glucocorticoids.Monogr Endocrinol. 1979;12:449-65. doi: 10.1007/978-3-642-81265-1_24. Monogr Endocrinol. 1979. PMID: 386088 Review. No abstract available.
Cited by
-
Initial serum creatinine concentration affects clinical outcomes in patients with IgA nephropathy treated with mycophenolate mofetil combined with low-dose prednisone.Exp Ther Med. 2020 May;19(5):3369-3376. doi: 10.3892/etm.2020.8573. Epub 2020 Mar 5. Exp Ther Med. 2020. PMID: 32266035 Free PMC article.
-
Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy.Kaohsiung J Med Sci. 2015 Jan;31(1):42-6. doi: 10.1016/j.kjms.2014.10.004. Epub 2014 Dec 2. Kaohsiung J Med Sci. 2015. PMID: 25600919 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.Clin Pharmacokinet. 2005;44(1):61-98. doi: 10.2165/00003088-200544010-00003. Clin Pharmacokinet. 2005. PMID: 15634032 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources